BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Boehringer Ingelheim
Cantor Fitzgerald
Federal Trade Commission
Citi
Chinese Patent Office
Dow
Healthtrust
Teva

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,020,001

« Back to Dashboard

Summary for Patent: 6,020,001
Title: Compositions for treating migraine
Abstract:A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient. The film-coated solid dosage forms are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
Inventor(s): Phillips; Anthony John (Ware, GB), Winterborn; Ian Keith (North Mississauga, CA), Padfield; John Malcolm (Middlesex, GB)
Assignee: Glaxo Group Limited (Greenford, GB)
Application Number:09/121,530
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use; Process;

Drugs Protected by US Patent 6,020,001

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,020,001

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9104890Mar 08, 1991
PCT/EP92/00460Mar 02, 1992

International Patents Family Members for US Patent 6,020,001

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom 2254784 ➤ Subscribe
Cyprus 2011 ➤ Subscribe
Czech Republic 9301849 ➤ Subscribe
Czech Republic 282352 ➤ Subscribe
Germany 69225421 ➤ Subscribe
Denmark 0503440 ➤ Subscribe
European Patent Office 0503440 ➤ Subscribe
Spain 2117015 ➤ Subscribe
France 2673538 ➤ Subscribe
United Kingdom 9204761 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Federal Trade Commission
Johnson and Johnson
Fuji
Harvard Business School
Citi
Cantor Fitzgerald
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot